Elsevier

Journal of Hepatology

Volume 11, Issue 3, November 1990, Pages 349-353
Journal of Hepatology

Regular paper
Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin

https://doi.org/10.1016/0168-8278(90)90220-LGet rights and content

Abstract

The technique of ‘targeting’ cytotoxic drugs by mixing them with the contrast medium lipiodol is now widely used in Japan and the Far East where it has been reported to enhance response rates in patients with hepatocellular carcinoma. In the present study 19 patients with this tumour were treated with intra-(hepatic)arterial adriamycin (60 mg/m2), at least one course of which was combined with lipiodol (10–20 ml). Two patients (11%) had a remission as indicated by a significant fall in serum alphafetoprotein and there was a reduction of tumour size in one of these. The median survival period was 3 months (range 1–18) with the two responding patients surviving 8 and 12 months. This response rate was no better than the figure of 14% seen in 31 consecutive patients treated with intravenous adriamycin at the same dose, and the survival curves of the two groups of patients were not significantly different. Lipiodol in combination with adriamycin is not superior to intravenous adriamycin administered alone.

References (23)

  • PJ Johnson et al.

    Induction of remission in hepatocellular carcinoma with doxorubicin

    Lancet

    (1978)
  • T Konno et al.

    Effect of arterial administration of high-molecular-weight antkancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report

    Eur J Cancer Clin Oncol

    (1983)
  • CL Vogel et al.

    A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

    Cancer

    (1977)
  • CLM Olweny et al.

    Further experience in treating patients with hepatocellular carcinoma in Uganda

    Cancer

    (1980)
  • G Falkson et al.

    Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

    Cancer

    (1978)
  • TK Choi et al.

    Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy

    Cancer

    (1984)
  • G Falkson et al.

    Primary Liver Cancer. An Eastern Cooperative Oncology Group trial

    Cancer

    (1984)
  • RT Chelbowski et al.

    Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspects

    Cancer

    (1981)
  • YZ Patt et al.

    Hepatocellular carcinoma. A retrospective analysis of treatment to manage disease confined to the liver

    Cancer

    (1988)
  • T Konno et al.

    Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium

    Cancer

    (1984)
  • H Ohishi et al.

    Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents

    Radiology

    (1985)
  • Cited by (0)

    View full text